REFERENCES
- Als-Nielsen B, Chen WD, Gluud C, et al. 2003. Association of funding and conclusions in randomized drug trials—A reflection of treatment effect or adverse events? JAMA—J Am Med Assoc 290(7):921–8
- Anonymous. 2013a. Problems with scientific research: How science goes wrong. The Economist, October 19. Available online at http://www.economist.com/news/leaders/21588069-scientific-research-has-changed-world-now-it-needs-change-itself-how-science-goes-wrong (accessed December 30, 2014)
- Anonymous. 2013b. Unreliable research: Trouble at the lab. The Economist, October 19. Available at http://www.economist.com/news/briefing/21588057-scientists-think-science-self-correcting-alarming-degree-it-not-trouble (accessed December 30, 2014)
- Aviv R. 2014. Annals of science: A valuable reputation. The New Yorker, February 10. Available at http://www.newyorker.com/magazine/2014/02/10/a-valuable-reputation (accessed December 30, 2014)
- Barrow C and Conrad JWJ. 2006. Assessing the reliability and credibility of industry science and scientists. Environ Health Perspect 114:153–5
- Bebarta V, Luyten D, and Heard K. 2003. Emergency medicine animal research: Does use of randomization and blinding affect the results? Acad Emer Med: Offic J Soc Acad Emer Med 10(6):684–7
- Becker RA, Janus ER, White RD, et al. 2009. Good laboratory practices and safety assessments. Environ Health Perspect 117:A 482–3
- Becker RA, Janus ER, White RD, et al. 2010. Good laboratory practices: Becker et al. respond. Environ Health Perspect 118:A 194–5
- Begley CG and Ellis LM. 2012. Drug development: Raise standards for preclinical cancer research. Nature 483(7391):531–3
- Bekelman JE, Li Y, and Gross CP. 2003. Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA—J Am Med Assoc 289(4):454–65
- Benner M, and Sandstrom U. 2000. Institutionalizing the triple helix: Research funding and norms in the academic system. Research Policy 29:291–301
- Bes-Rastrollo M, Schulze MB, Ruiz-Canela M, et al. 2013. Financial conflicts of interest and reporting bias regarding the association between sugar-sweetened beverages and weight gain: A systematic review of systematic reviews. PLoS Med 10(12):e1001578; discussion e
- Blumenthal D. 2003. Academic-industrial relationships in the life sciences. New Engl J Med 349(25):2452–9
- Bohannon J. 2013. Who's afraid of peer review? Science 342(6154):60–65
- Boyd I. 2013. Research: A standard for policy-relevant science. Nature 501(7466):159–60
- Chapman P. 2012. Crossing the scientific line: sins of omission and commission. Mar Pollut Bull 64:457–458
- Chavalarias D and Ioannidis JP. 2010. Science mapping analysis characterizes 235 biases in biomedical research. J Clin Epidem 63(11):1205–15
- Chirico R, Frenkel M, Magee J, et al. 2013. Improvement of quality in publication of experimental thermophysical property data: Challenges, assessment tools, global implementation, and online support. J Chem Eng Data 58(10):2699–716
- Claxton LD. 2007. A review of conflict of interest, competing interest, and bias for toxicologists. Toxicol Industr Health 23:557–571
- Couzin-Frankel J. 2013. When mice mislead. Science 342(6161):922–3, 5
- Crossen C. 1994. Tainted Truth: The Manipulation of Fact in America. Simon And Schuster, New York, New York, USA
- Crossley NA, Sena E, Goehler J, et al. 2014. Empirical evidence of bias in the design of empirical stroke studies: A metaepidemiological approach. Stroke 39:929–34
- Cumming G. 2014. The new statistics: Why and how. Psychol Sci 25(1):7–29
- Curzer, H and Santillanes G. 2012. Manageing conflict of interest in research: Some suggestions for investigators. Account Res: Policies Qual Assur 19(3):143–155
- Denworth L. 2008. Toxic Truth: A Scientist, a Doctor and the Battle Over Lead. Beacon Press, Boston, MA, USA
- Egilman D. 2006. Corporate corruption of science—The case of chromium(VI). Inter J Occup Environ Health 12(2):169–76
- Elliott KC and Resnik DB. 2014. Science, policy, and the transparency of values. Environ Health Perspect 122:647–50
- Fanelli D. 2009. How many scientists fabricate and falsify research? A systematic review and meta-analysis of survey data. PloS One 4(5):e5738
- Fanelli D. 2010. Do pressures to publish increase scientists' bias? An empirical support from US states data. PloS One 5(4):e10271
- Fang FC, Steen RG, and Casadevall A. 2012. Misconduct accounts for the majority of retracted scientific publications. Proc of Nat Acad Sci USA 109(42):17028–33
- Farrar D, Alexander L, Yuan LL, et al.. 2014. Regional observational studies: Addressing confounding. In: Norton S, Cormier S, and Suter G (eds), Ecological Causal Assessment, pp 187–202. CRC Press, Boca Raton, FL, USA
- Field, TG Jr. 1993. The science court is dead: Long live the science court. RISK 4:95–8
- Fore, LS. 2003. Developing Biological Indicators: Lessons Learned from Mid-Atlantic Streams. EPA 903/R-003/003. U.S. Environmental Protection Agency, Office of Environmental Information and Mid-Atlantic Integrated Assessment Program, Region 3, Ft. Meade, MD
- Gates, S. 2002. Review of methodology of quantitative reviews using meta-analysis in ecology. J Animal Ecol 71:547–57
- Gilbert N. 2009. Editor will quit over hoax paper. Nature News Published online June 15. Available at http://www.nature.com/news/2009/090615/full/news.2009.571.html (accessed December 30, 2014).
- Hart B, Lundh A, and Bero L. 2011. Effect of reporting bias on meta-analyses of drug trials: Reanalysis of meta-analyses. BMJ 343:d7202
- Hayes, T.ND. Our world… our future Atrazine lovers… Available at http://www.atrazinelovers.com (accessed December 30, 2014)
- Hayes T. 2004. There is no denying this: Defusing the confusion about atrazine. BioScience 54:1138–49
- Hayes T, Anderson, L, Beasley V, et al. 2011. Demasculinization and feminization of male gonads by atrazine: Consistent effects across vertebrate classes. J Steroid Biochem Molecular Biol 127:64–73
- Hicks J. 2013. Opinion: Ethics training in science. The Scientist May 14. Available at http://www.the-scientist.com/?articles.view/articleNo/35543/title/Opinion–Ethics-Training-in-Science/ (accessed December 30, 2014)
- Hollister JW and Walker HA. 2014. Beyond data: Reproducible research in ecology and environmental sciences. Frontiers Ecol Environ 5(1):11–2
- Hopewell S, Boutron I, Altman DG, et al. 2013. Incorporation of assessments of risk of bias of primary studies in systematic reviews of randomized trials: A cross-sectional study. BMJ Open 3:e003342
- Hurlbert, SH. 1984. Pseudoreplication and the design of ecological field experiments. Ecol Mono 54(2):187–211
- Ioannidis JP. 2006. Evolution and translation of research findings: From bench to where? PLoS Clin Trials 1(7):e36
- Ioannidis JP and Trikalinos TA. 2005. Early extreme contradictory estimates may appear in published research: The Proteus phenomenon in molecular genetics research and randomized trials. J Clin Epidem 58(6):543–9
- Ioannidis JP, Allison DB, Ball CA, et al. 2009. Repeatability of published microarray gene expression analyses. Nature Genetics 41(2):149–55
- Kilkenny C, Parsons N, Kadyszewski E, et al. 2009. Survey of the quality of experimental design, statistical analysis and reporting of research using animals. PloS One 4(11):e7824
- Kilkenny C, Browne W, Cuthill I, et al. 2010. Improving bioscience research report: The ARRIVE guidelines for reporting animal research. PLoS Biol 8(6):e1000412. doi:10.1371/journal.pbio
- Krauth D, Woodruff TJ, and Bero L. 2013. Instruments for assessing risk of bias and other methodological criteria of published animal studies: A systematic review. Environ Health Perspect 121:985–92
- Krauth D, Anglemyer A, Phillips R, et al. 2014. Nonindustry-sponsored precliniccal studies on statins yield greater efficacy estimates than industry sponsored studies: A meta-analysis. PLOS Biol 12(1):E1001770
- Kuehn RR. 2004. Suppression of environmental science. Amer J Law & Med 30(2–3):333–69
- Lee KP, Schotland M, Bacchetti P, et al. 2002. Association of journal quality indicators with methodological quality of clinical research articles. JAMA—J Am Med Assoc 287(21):2805–8
- Lexchin J, Bero LA, Djulbegovic B, et al. 2003. Pharmaceutical industry sponsorship and research outcome and quality: Systematic review. BMJ 326(7400):1167–70
- Lund A, Sismondo S, Lexchin J, et al. 2012. Industry sponsorship and research outcomes (review). Cochrane Database System Rev 12: Art. No.:MR000033
- Macleod MR, Fisher M, O’Collins V, et al. 2008. Reprint: Good laboratory practice: Preventing introduction of bias at the bench. J Cereb Blood Flow Metab 29(2):221–3
- Master Z, McDonald M, Williams-Jones B. 2012. Promoting research on research integrity in Canada. Account Res: Policies and Qual Assur 19(1):47–52
- Matten S. 2012. Transmittal of the Meeting Minutes of the FIFRA SAP Meeting held June 12–14, 2012 on the Scientific Issues Associated with “Problem Formulation for the Reassessment of ecological Effects from the Use of Atrazine.” EPA-HQ-OPP-2012-0230-0220. Available at http://www.regulations.gov/#!documentDetail;D=EPA-HQ-OPP-2012-0230-0220 (accessed December 30, 2014)
- McCarty LS, Borgert CJ, and Mihaich EM. 2012. Information quality in regulatory decision making: Peer review versus good laboratory practice. Environ Health Persp 120(7):927–34
- McGarity T and Wagner W. 2008. Bending Science: How Special Interests Corrupt Public Health Research. Harvard University Press, Cambridge, MA, USA
- Michaels D. 2008. Doubt is Their Product. Oxford University Press, New York, NY, USA
- Michaels D and Wagner W. 2003. Science and government. Disclosure in regulatory science. Sci 302(5653):2073
- Michaels D, Monforton C, and Lurie P. 2006. Selected science: An industry campaign to undermine an OSHA hexavalent chromium standard. Environ Health: A Global Access Sci Source 5:1–8
- Mulane K and Williams M. 2013. Bias in research: The rule rather than the exception? Ed Update September 17(40). Available at http://editorsupdate.elsevier.com/issue-40-september-2013/bias-in-research-the-rule-rather-than-the-exception/ (accessed December 30, 2014)
- Mullard A. 2011. Reliability of “new drug target” claims called into question. Nature Reviews Drug Discovery 10(9):643–4
- Myers JP, Vom Saal FS, Akingbemi BT, et al. 2009a. Why public health agencies cannot depend on good laboratory practices as a criterion for selecting data: The case of Bisphenol A. Environ Health Perspect 117:309–15
- Myers JP, Vom Saal FS, Taylor JA, et al. 2009b. Good laboratory practices: Myers et al. repond. Environ Health Perspect 117:A 483–4
- Nieto A, Mazon A, Pamies R, et al. 2007. Adverse effects of inhaled corticosteroids in funded and nonfunded studies. Arch Intern Med 167(19):2047–53
- Nosek BA, Spies JR, and Motyl M. 2012. Scientific utopia: II. Restructuring incentives and practices to promote truth over publishability. Perspect Psychol Sci 7(6):615–31
- NRC. 2014. Review of EPA's Integrated Risk Information System (IRIS) Process. National Research Council of the National Academies of Science, Washington, DC, USA
- Nuzzo R. 2014. Statistical errors: P values, the “gold standard” of statistical validity, are not as reliable as many scientists assume. Nature 506:150–2
- Oreskes N and Conway EM. 2010. Merchants of Doubt. Bloomsbury Press, New York, NY, USA
- Peng RD, Dominici F, and Zeger SL. 2006. Reproducible epidemiologic research. Amer J Epidem 163(9):783–9
- The PLOS Medecine Editors. 2012. Does conflict of interest disclosure worsen biase? PLOS Med 9(4):e1001210
- Priem J. 2013. Scholarship: Beyond the paper. Nature 495(7442):437–40
- Prinz F, Schlange T, and Asadullah K. 2011. Believe it or not: How much can we rely on published data on potential drug targets? Nature Rev Drug Discovery 10(9):712
- Rabesandratana T. 2013. The seer of science publishing. Sci 342(6154):66–7
- Resnik DB and Elliott KC. 2013. Taking financial relationships into account when assessing research. Account Res 20:184–205
- Rooney AA, Boyles AL, Wolfe MS, et al. 2014. Systematic review and evidence integration for literature-based environmental health science assessments. Environ Health Perspect 122:711–8
- Rosenstock L and Lee LJ. 2002. Attacks on science: The risks to evidence-based policy. Amer J Public Health 92(1):14–8
- Rothman KJ. 1993. Conflict of interest. The new McCarthyism in science. JAMA—J Amer Med Assoc 269(21):2782–4
- Rothman KJ and Evans S. 2005. Extra scrutiny for industry funded trials. BMJ 331(7529):1350–1
- Schulz KF, Chaimers I, Hayes RJ, et al. 1995. Empirical evidence of bias: Dimensions of methodological quality asseociated with estimates of treatment effects in controlled trials. JAMA 273:408–12
- Sena ES, van der Worp HB, Bath PM, et al. 2010. Publication bias in reports of animal stroke studies leads to major overstatement of efficacy. PLoS Biol 8(3):e1000344
- Shrader-Frechette K. 2012. Research integrity and conflicts of interest: The case of unethical research-misconduct charges filed by Edward Calabrese. Account Res: Policies Qual Assur 19(4):220–42
- Shrader-Frechette K and Oreskes N. 2011. Symmetrical transparency in science. Sci 332(6030):663–4
- Simmons JP, Nelson LD, and Simonsohn U. 2011. False-positive psychology: Undisclosed flexibility in data collection and analysis allows presenting anything as significant. Psychol Sci 22(11):1359–66
- Simonsohn U, Nelson LD, and Simmons JP. 2013. P-curve: A key to the file-drawer. J Exper Psychol Gen 143(2):534–47
- Slovic P, Malmfors T, Mertix C, et al. 1997. Evaluating chemical risks: Results of a survey of the British Toxicological Society. Hum Exp Toxicol 16:289–304
- Smith R. 2006. Peer review: A flawed process at the heart of science and journals. J Royal Soc Med 99(4):178–82
- Solomon, K, Carr J, Du Peez L, et al. 2008. Effects of atrazine on fish, amphibians, and aquatic reptiles: A critical review. Critic Rev Toxicol 38:721–772
- Steen RG, Casadevall A, and Fang FC. 2013. Why has the number of scientific retractions increased? PloS One 8(7):e68397
- Stodden V, Leisch F, and Peng RD (eds). 2014. Implementing Reproducible Research, Chapman & Hall/CRC Press, Boca Raton, FL, USA
- Stossel TP. 2005. Regulating academic-industrial research relationships—Solving problems or stifling progress? New Engl J Med 353(10):1060–5
- Sutherland WJ, Spiegelhalter D, and Burgman MA. 2013. Policy: Twenty tips for interpreting scientific claims. Nature 503(7476):335–7
- Syngenta. 2014a. Amphibians. Available at http://www.atrazine.com/Amphibians/atrazine_amphibians.aspx (accessed December 30, 2014)
- Syngenta. 2014b. Ethics complaints against Dr. Tyrone Hayes. Available at http://www.atrazine.com/Amphibians/tyrone-hayes.aspx (accessed December 30, 2014)
- Tong S and Olsen J. 2005. The threat to scientific integrity in environmental and occupational medicine. Occup Environ Med 62(12):843–6
- Trzupek R. 2011. Regulators Gone Wild: How the EPA is Ruining American Industry. Encounter Books, Jackson, TN, USA.
- Tsilidis K, Panagiotou O, Sena E, et al. 2013. Evaluation of excess significance bias in animal studies of neurological diseases. PLoS Biol 11(7):e1001609
- Tweedale T. 2010. Good laboratory practices and safety assessments: another view. Environ Health Perspect 118:A 194–5
- Underwood AJ. 1981. Techniques of analysis of variance in experimental marine biology and ecology. Ocean Mar Biol:Ann Rev 9:513–605
- Valliantos EG and Jenkins M. 2014. Poison Spring: The Secret History of Pollution and the EPA. Bloomsbury Press, New York, NY, USA
- Van Noorden R. 2011. Science publishing: The trouble with retractions. Nature 478(7367):26–8
- Van Noorden R. 2013. Open access: The true cost of science publishing. Nature 495(7442):426–9
- Van Noorden R. 2014. Publishers withdraw more than 120 gibbberish papers. Nature doi:10.1038/nature.2014.14763
- Wagner W and Michaels D. 2004. Equal treatment for regulatory science: Extending the controls governing the quality of public research to private research. Amer J Law Med 30:119–54
- Wagner W and McGarity T. 2009. Regulatory reinforcement of journal conflict of interest disclosures: How could disclosure of interests work better in medicine, epidemiology and public health? J Epidem Commun Health 63(8):606–7
- Waltz E. 2009. GM crops: Battlefield. Nature 461(7260):27–32
- Wittington CJ, Kendall T, Fonagy P, et al. 2004. Selective serotonin reuptake inhibitors in childhood depression: Systematic review of published versus unpublished reviews. The Lancet 363:1341–5
- Wood L, Egger M, Gluud LL, et al. 2008. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: Meta-epidemiological study. BMJ 336:601
- Wood MC. 2014. Nature's Trust. Cambridge University Press, New York, NY, USA
- Yong E. 2012. Bad copy: In the wake of high-profile controversies, psychologists are facing up to problems with replication. Nature 485:298–300